Skip to content

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.05B+31.9%
AbbVie logo
AbbVieABBV
$265M+12.8%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$9K-90.9%
Regenxbio logo
RegenxbioRGNX
$1.24M+20.6%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$0-100%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s capex?
Immix Biopharma, Inc. (IMMX) reported capex of $32.49K in Q1 2026.
How has Immix Biopharma, Inc.'s capex changed year-over-year?
Immix Biopharma, Inc.'s capex decreased by 52.0% year-over-year, from $67.71K to $32.49K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.